Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label New Standard-of-Care First-Line Therapy. Show all posts
Showing posts with label New Standard-of-Care First-Line Therapy. Show all posts
Wednesday, August 21, 2024

Ipsen’s Onivyde Regimen, a Potential New Standard-of-Care First-Line Therapy in Metastatic Pancreatic Adenocarcinoma, Approved by FDA

›
Ipsen (Euronext: IPN; ADR: IPSEY) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug ap...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.